<DOC>
	<DOCNO>NCT00827242</DOCNO>
	<brief_summary>The purpose study determine whether experimental drug know tadalafil give daily reduce symptom associate Benign Prostatic Hyperplasia ( strain , urinary frequency , feel like bladder still full , etc . )</brief_summary>
	<brief_title>Study Treat Patients Who Have Signs Symptoms Benign Prostatic Hyperplasia ( BPH ) With Tadalafil Daily</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Men 45 year age old Benign Prostatic Hyperplasia ( BPH ) also refer BPHLUTS [ low urinary tract symptom ] base disease diagnostic criterion start study . Provide sign informed consent start study . Have take Finasteride therapy least 3 month study drug dispense Dutasteride therapy least 6 month study drug dispense . Have take BPH therapy ( include herbal preparation ) , overactive bladder ( OAB ) therapy , erectile dysfunction ( ED ) therapy least 4 week prior study drug dispense . Agree use approve experimental pharmacologic BPH , OAB , ED treatment anytime study Have LUTS Total International Prostate Symptom Score ( IPSS ) great equal 13 study drug dispense . Have reduce peak urine flow rate study drug dispense ( measure special toilet equipment ) . Demonstrate compliance study drug administration requirement . Treated nitrate cardiac condition . Have unstable angina angina require treatment . Have follow past 90 day : Heart attack , also know myocardial infarction ( MI ) ; Heart bypass surgery ( call coronary artery bypass graft surgery ) ; Had procedure open blood vessel heart know angioplasty stent placement ( percutaneous coronary intervention ) . Have high low blood pressure Have problem kidney , liver , nervous system . Have uncontrolled diabetes . Have stroke significant injury brain spinal cord . Have prostate cancer , treat cancer clinical evidence prostate cancer ( ProstateSpecific Antigen [ PSA ] great 10 nanograms/milliliter [ ng/ml ] start study ) .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Signs Symptoms</keyword>
	<keyword>Prostatic Hyperplasia</keyword>
	<keyword>Hyperplasia</keyword>
	<keyword>Genital Diseases , Male</keyword>
	<keyword>Prostatic Diseases</keyword>
	<keyword>BPH-LUTS</keyword>
</DOC>